or
forgot password
  • cancer clinical trials in baltimore, MD

  • Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial
    Bloomberg School of Public Health
    Baltimore, Maryland 21205
    Breast Cancer, Colon Cancer, Rectum Cancer, Cervix Cancer, Prostate Cancer, Lung Cancer
    Early or Delayed Fludarabine and Rituximab in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia
    Greenebaum Cancer Center at University of Maryland Medical Center
    Baltimore, Maryland 21201
    Leukemia
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Greater Baltimore Medical Center
    Baltimore, Maryland 21204
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital
    Baltimore, Maryland 21231
    Recurrent Small Cell Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Vaccine Therapy in Treating Patients With Breast Cancer
    MedStar Union Memorial Hospital

    Trial Locations
    MedStar Union Memorial Hospital
    MedStar Good Samaritan Hospital Cancer Center
    Breast Cancer
    Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML)
    Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
    University of Maryland Greenebaum Cancer Center
    Baltimore, Maryland 21201
    Ovarian Cancer, Renal Cancer, Non-small Cell Lung Cancer, Small Cell Lung Cancer, Solid Tumors, Multiple Myeloma, Lymphoma
    High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    Greenebaum Cancer Center at University of Maryland Medical Center

    Trial Locations
    Greenebaum Cancer Center at University of Maryland Medical Center
    St. Agnes Hospital Cancer Center
    Lung Cancer, Radiation Toxicity
    Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer
    John Hopkins University
    Baltimore, Maryland 21231
    Breast Cancer, Carcinoma of the Breast
    Lapatinib and Trastuzumab With or Without Endocrine Therapy
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Bunting-Blaustein Cancer Research
    Baltimore, Maryland 21231-1000
    Breast Cancer
    Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery
    Greenebaum Cancer Center at University of Maryland Medical Center
    Baltimore, Maryland 21201
    Lung Cancer
    S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Trial Locations
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Greenebaum Cancer Center at University of Maryland Medical Center
    Leukemia
    Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure
    Sidney Kimmel Comprehensive Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Breast Cancer
    Combination Chemotherapy With or Without Lestaurtinib in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Trial Locations
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
    Greenebaum Cancer Center at University of Maryland Medical Center
    Leukemia
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Greater Baltimore Medical Center
    Baltimore, Maryland 21204
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Activated White Blood Cells in Treating Patients Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Stage II or Stage III Multiple Myeloma
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Baltimore, Maryland 21231-2410
    Multiple Myeloma and Plasma Cell Neoplasm
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center

    Trial Locations
    Harry and Jeanette Weinberg Cancer Institute at Franklin Square Hospital Center
    Greenebaum Cancer Center at University of Maryland Medical Center
    Good Samaritan Hospital of Maryland
    St. Agnes Hospital Cancer Center
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma
    Greenebaum Cancer Center at University of Maryland Medical Center
    Baltimore, Maryland 21201
    Neuroblastoma
    Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
    Greenebaum Cancer Center at University of Maryland Medical Center

    Trial Locations
    Greenebaum Cancer Center at University of Maryland Medical Center
    Greater Baltimore Medical Center Cancer Center
    St. Agnes Hospital Cancer Center
    Prostate Cancer
    Randomized Trial of Suicide Gene Therapy and Prostate Cancer
    Johns Hopkins University School of Medicine
    Baltimore, Maryland 21205
    Prostate Cancer
    A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia
    Research Site
    Baltimore, Maryland
    Hairy Cell Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Johns Hopkins University

    Trial Locations
    Johns Hopkins University
    Greater Baltimore Medical Center
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
    Johns Hopkins University School of Medicine Dept.ofJohnsHopkinsUniv.
    Baltimore, Maryland 21205
    Acromegaly
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Sinai Hospital of Baltimore

    Trial Locations
    Sinai Hospital of Baltimore
    Greater Baltimore Medical Center
    University of Maryland Greenebaum Cancer Center
    Veterans Administration Medical Center
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery
    John Hopkins Medical Center
    Baltimore, Maryland 21287
    Breast Cancer, Breast Surgery, Breast Reconstruction, Breast Reduction, Breast Augmentation
    Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
    Greenebaum Cancer Center at University of Maryland Medical Center
    Baltimore, Maryland 21201
    Colorectal Cancer
    Laparoscopic Approach to Cervical Cancer
    Greater Baltimore Medical Centre

    Trial Locations
    Greater Baltimore Medical Centre
    John Hopkins Hospital
    Cervical Cancer
    Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
    John Hopkins University

    Trial Locations
    John Hopkins University
    U of Maryland Medical Center
    Liver Transplantation
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Franklin Square Hospital Center

    Trial Locations
    Franklin Square Hospital Center
    Greater Baltimore Medical Center
    Mercy Medical Center
    Harry & Jeannette Weinberg Cancer Institute
    Hematology-Oncology Associates
    Breast Cancer
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Johns Hopkins University
    Baltimore, Maryland 21205
    Hepatic Veno-Occlusive Disease